Sarepta adds another gene therapy to its ever-expanding pipeline

Sarepta Therapeutics is officially taking onboard an experimental gene therapy developed by scientists at Nationwide Children's Hospital in Ohio, announcing Wednesday it had licensed the treatment for a type of muscular dystrophy.